```json
{
"content": [
{
"type": "paragraph",
"content": "North America remains the largest Disposable Ureteral Stent market, commanding over 38% regional share in 2023. Aggressive shift to outpatient lithotripsy, CMS reimbursement clarity, and mature integrated-delivery networks accelerate adoption. The fastest-growing Asia Pacific (22% share) is forecast a 9% CAGR through 2028; 1.2-billion aging population, universal-coverage schemes (Japan, S. Korea), and Beijing’s innovative medical device exemption shorten regulatory cycles, while Indian cath-lab build-outs attract OEM investments."
},
{
"type": "paragraph",
"content": "Europe’s 27% slice is propelled by the EU MDR-compliant product pipeline, cross-border health procurement, and green-hospital initiatives favoring single-use stents. Latin America (7%) benefits from public-private urology partnerships in Brazil/Mexico and tariff-free medical corridors under Pacific Alliance. Middle East & Africa (6%) growth hinges on Gulf Vision 2030 infrastructure and mandatory health-insurance expansions in UAE/Saudi; however, pricing pressures and logistical constraints temper volume gains."
}
},
"worldMapData": {
"regions": [
{ "name": "North America", "value": 38 },
{ "name": "Europe", "value": 27 },
{ "name": "Asia Pacific", "value": 22 },
{ "name": "Latin America", "value": 7 },
{ "name": "Middle East & Africa", "value": 6 }
]
}
}
```
